VRV. A. Ridin

V. A. Ridin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


V. A. Ridin has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Is technically complicated partial nephrectomy justified in renal cell carcinoma patients with normal contralateral kidney?

    by M. I. Volkova, V. A. Ridin, V. A. Cherniayev, A. V. Klimov, K. M. Figurin, A. A. Kirichek, V. B. Matveev

    Objective: to compare the results of partial (PN) and radical nephrectomy (RN) in patients with renal parenchymal tumors with nephrometric PADUA index ≥8 and/or RENAL index ≥7 and functioning contralateral kidney.Materials and methods. Medical data of 114 consecutive patients with renal cell carcinoma (RCC) cT1–3aN0M0 and functioning contralateral kidney were included into the study: 57 (50.0 %) persons undergone PN for tumors with nephrometric PADUA index ≥8 and/or RENAL index ≥7 (the main group), and 57 (50.0 %) patients undergone RN (the control group). The groups were comparable with regards to demographic characteristics, nephrometric parameters, morphological tumor features, and baseline glomerular filtration rate (р 0.05 for all). Median follow-up – 52.0 ± 23.6 (9.1–138.5) months.Results. Technically complicated PNs were associated with an increase of median surgery time (by 39 min, р = 0.06), blood loss (by 319 ml, p within the groups. Chronic kidney disease (CKD) progression rate was significantly higher in RN than in PN group (40 % vs 31.6 % respectively, р = 0.050), including more frequent development of CKD stages III–IV (31.6 % vs 26.3 % respectively; р = 0.034). There was no difference of long-term survival between PN and RN groups, and that included survival results stratified according to gender, age, baseline CKD stage, PADUA and RENAL indexes. Five-year recurrence-free survival was 94.1 % vs 92.2 % (р = 0.223), cancer-specific survival – 92.3 % vs 90.8 % (р = 0.443), cardio-specific survival – 91.6 % vs 77.9 % (р = 0.549), overall survival – 89.8 % vs 70.7 % respectively (р = 0.858).Conclusion. PN is effective and safe method of treatment in patients with renal parenchymal tumors with PADUA index ≥8 and/or RENAL index ≥7 and functioning contralateral kidney, providing significant functional benefit without survival compromising when compared with RN.


  • Results of kidney resection in patients with renal cell cancer with a high nephrometric index

    by M.I. Volkova, Federal State Budgetary Institution «National Medical Research Center for Oncology named after N.N. Blokhin» of Ministry of Health of Russian Federation, V.A. Ridin, V.A. Chernyaev, A.V. Klimov, K.M. Figurin

    Резекция почки является общепризнанным стан дартом в лечении больных клинически локализо ванными опухолями почечной паренхимы. Со вершенствование операционной техники привело к накоплению опыта технич


  • Open Access

    Clinical case of lymphoma of the seminal vesicle

    by V. B. Matveev, V. A. Ridin, V. N. Sholokhov, V. M. Snitkin, V. A. Chernyaev, B. V. Bukharkin, M. S. Makhotina, S. N. Berdnikov, D. A. Khalikova

    The article presents a clinical case of seminal vesicle lymphoma in a 73-year-old man who was sent for examination at the N.N. Blokhin National Medical Research Center of Oncology with suspected prostate tumor.

  • Long-term functional results of partial nephrectomy in patients with tumors of solitary kidney

    by M. Volkova, K.M. Figurin, V.A. Cherniaev, S.V. Alborov, V.A. Ridin, A.V. Klimov, V.B. Matveev

  • Open Access

    Clinical prognostic factors of bilateral synchronous renal cancer

    by M I Komarov, V B Matveev, M I Volkova, I G Komarov, V A Ridin, Комаров Максим Игоревич, Матвеев Всеволод Борисович, Волкова Мария Игоревна, Комаров Игорь Геннадьевич, Ридин Владимир Александрович

    The aim of the study is to assess the positive and negative prognostic factors of survival in patients with bilateral synchronous renal cancer (BRC). Materials and methods. The study was conducted on the basis of N.N.Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation. Cohort of patients with the synchronous BRC consisted of 160 patients between 1996 and 2014. All patients after finishing treatment were observed on an ambulatory basis during the period from 11 months to 12 years (median follow-up 81.05±46.7 months). We studied factors affecting 5-year survival rate, both positive and negative. Statistical analysis of the obtained results carried out using generally accepted statistical methods such as SPSS 23.0 - block of programs for Windows. Results. In case of synchronous BRC in 2/3 (65%) of patients the first kidney was operated on using organ-preserving surgery, in 1/4 of patients (n=21, 26.2%) both kidneys were operated on using organ-preserving surgery. In case of synchronous renal cancer the best results of survival, but without statistical significance (p=0.112) had patients with bilateral renal cancer who operated on using organ-preserving surgery. The 10-year overall survival in this group of patients was 90.5% in comparison with 62.5% - when nephrectomy was performed on the first stage and 76.4% in patients who had nephrectomy performed because of the renal cancer in the second kidney. Conclusions. The main factors affecting the 5-year survival rate of patients with synchronous BRC were: smoking, primary tumor size, age and type of surgery.